Michael May

President and CEO

Centre for Commercialization of Regenerative Medicine (CCRM)

All Sessions by Michael May

Printer Friendly See Full Agenda

Agenda: Day 1 Oct 5, 2020

4:00 pm

4:00 pm


Is Cell Gene Therapy ‘IT’?

Although still considered by some an experimental technique, cell gene therapy (CGT), which focuses on the genetic modification of cells, is poised to become much more prevalent. Researchers are constantly unveiling new approaches to gene therapy. Inform your development pipeline with an in-depth understanding of these strategies, including:

  • Replacing a mutated disease-causing gene with a healthy copy of the gene
  • Inactivating, or “knocking out,” a mutated gene that is functioning improperly
  • Introducing a new gene into the body to help fight a disease

Equip your team with actionable insights in your development of efficacious gene therapy products

Agenda: Day 2 Oct 6, 2020